Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,093 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $467.05 | 4 | $0 (2024) |
| Mindray DS USA, Inc. | $339.59 | 3 | $0 (2024) |
| ABBVIE INC. | $164.54 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $121.83 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $677.97 | 6 | Mindray DS USA, Inc. ($339.59) |
| 2023 | $290.95 | 4 | AstraZeneca Pharmaceuticals LP ($129.58) |
| 2021 | $124.09 | 1 | AstraZeneca Pharmaceuticals LP ($124.09) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/29/2024 | Mindray DS USA, Inc. | TE7 MAX (Device), TE X | Food and Beverage | In-kind items and services | $297.61 | General |
| Category: ULTRASOUND | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $66.79 | General |
| Category: Rare Disease | ||||||
| 07/09/2024 | Mindray DS USA, Inc. | TE7 MAX (Device), TE X | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: ULTRASOUND | ||||||
| 05/30/2024 | Mindray DS USA, Inc. | TE7 MAX (Device), TE X | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ULTRASOUND | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $146.59 | General |
| Category: Rare Disease | ||||||
| 03/12/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/20/2023 | ABBVIE INC. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/18/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/20/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: COVID-19 | ||||||
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $129.58 | General |
| Category: Rare Disease | ||||||
| 06/17/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 805 | 825 | $846,712 | $94,992 |
| 2022 | 5 | 555 | 560 | $728,845 | $79,792 |
| 2021 | 4 | 362 | 369 | $525,694 | $64,127 |
| 2020 | 4 | 353 | 353 | $515,961 | $59,382 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 447 | 461 | $580,271 | $68,120 | 11.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 129 | 131 | $121,333 | $12,863 | 10.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 62 | 64 | $119,572 | $11,248 | 9.4% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 25 | 25 | $13,586 | $1,338 | 9.8% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 104 | 106 | $4,934 | $607.38 | 12.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 26 | 26 | $4,716 | $540.79 | 11.5% |
| 76604 | Ultrasound scan of chest | Facility | 2023 | 12 | 12 | $2,300 | $275.82 | 12.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 371 | 373 | $566,262 | $62,829 | 11.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 40 | 40 | $75,539 | $8,263 | 10.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 60 | 60 | $62,744 | $6,250 | 10.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 33 | 33 | $20,307 | $2,102 | 10.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 51 | 54 | $3,992 | $347.83 | 8.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 240 | 244 | $368,238 | $44,894 | 12.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 48 | 49 | $86,856 | $11,124 | 12.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 56 | 58 | $58,938 | $6,859 | 11.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 18 | 18 | $11,662 | $1,250 | 10.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 238 | 238 | $360,808 | $41,075 | 11.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 60 | 60 | $105,240 | $12,944 | 12.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 36 | 36 | $36,936 | $4,190 | 11.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 19 | 19 | $12,977 | $1,174 | 9.0% |
About Jeffrey Greco
Jeffrey Greco is a Emergency Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1013329283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jeffrey Greco has received a total of $1,093 in payments from pharmaceutical and medical device companies, with $677.97 received in 2024. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($1,093).
As a Medicare-enrolled provider, Greco has provided services to 2,075 Medicare beneficiaries, totaling 2,107 services with total Medicare billing of $298,293. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Manhasset, NY
- Active Since 05/22/2014
- Last Updated 05/01/2018
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1013329283
Products in Payments
- ANDEXXA (Biological) $342.96
- TE7 MAX (Device) $339.59
- DALVANCE (Drug) $164.54
- LOKELMA (Drug) $124.09
- Veklury (Drug) $121.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Manhasset
Christopher Raio, Md, MD
Emergency Medicine — Payments: $187,256
Joshua Levine, Md, MD
Emergency Medicine — Payments: $13,958
Laura Patruno, Pa, PA
Emergency Medicine — Payments: $5,785
Jason Zemmel D'amore, Md, MD
Emergency Medicine — Payments: $4,719
Dr. Tadeusz Korszun, Md, MD
Emergency Medicine — Payments: $2,243
David Silver, Md, MD
Emergency Medicine — Payments: $1,153